Toll-like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1beta in Mice

Overview

Journal Gastroenterology

Specialty Gastroenterology

Date 2010 Mar 30

PMID 20347818

Citations 391

Authors

Kouichi Miura

Yuzo Kodama

Sayaka Inokuchi

Bernd Schnabl

Tomonori Aoyama

Hirohide Ohnishi

Jerrold M Olefsky

David A Brenner

Ekihiro Seki

Affiliations

Soon will be listed here.

Abstract

Background & Aims: Development of nonalcoholic steatohepatitis (NASH) involves the innate immune system and is mediated by Kupffer cells and hepatic stellate cells (HSCs). Toll-like receptor 9 (TLR9) is a pattern recognition receptor that recognizes bacteria-derived cytosine phosphate guanine (CpG)-containing DNA and activates innate immunity. We investigated the role of TLR9 signaling and the inflammatory cytokine interleukin-1beta (IL-1beta) in steatohepatitis, fibrosis, and insulin resistance.

Methods: Wild-type (WT), TLR9(-/-), IL-1 receptor (IL-1R)(-/-), and MyD88(-/-) mice were fed a choline-deficient amino acid-defined (CDAA) diet for 22 weeks and then assessed for steatohepatitis, fibrosis, and insulin resistance. Lipid accumulation and cell death were assessed in isolated hepatocytes. Kupffer cells and HSCs were isolated to assess inflammatory and fibrogenic responses, respectively.

Results: The CDAA diet induced NASH in WT mice, characterized by steatosis, inflammation, fibrosis, and insulin resistance. TLR9(-/-) mice showed less steatohepatitis and liver fibrosis than WT mice. Among inflammatory cytokines, IL-1beta production was suppressed in TLR9(-/-) mice. Kupffer cells produced IL-1beta in response to CpG oligodeoxynucleotide. IL-1beta but not CpG-oligodeoxynucleotides, increased lipid accumulation in hepatocytes. Lipid accumulation in hepatocytes led to nuclear factor-kappaB inactivation, resulting in cell death in response to IL-1beta. IL-1beta induced fibrogenic responses in HSCs, including secretion of tissue inhibitor of metalloproteinase-1. IL-1R(-/-) mice had reduced steatohepatitis and fibrosis, compared with WT mice. Mice deficient in MyD88, an adaptor molecule for TLR9 and IL-1R signaling, also had reduced steatohepatitis and fibrosis. TLR9(-/-), IL-1R(-/-), and MyD88(-/-) mice had less insulin resistance than WT mice on the CDAA diet.

Conclusions: In a mouse model of NASH, TLR9 signaling induces production of IL-1beta by Kupffer cells, leading to steatosis, inflammation, and fibrosis.

Citing Articles

The Role of TLRs in Obesity and Its Related Metabolic Disorders.

Campos-Bayardo T, Roman-Rojas D, Garcia-Sanchez A, Cardona-Munoz E, Sanchez-Lozano D, Totsuka-Sutto S Int J Mol Sci. 2025; 26(5).

PMID: 40076851 PMC: 11900219. DOI: 10.3390/ijms26052229.

The role of the interleukin family in liver fibrosis.

Zhang Z, Wang J, Li H, Niu Q, Tao Y, Zhao X Front Immunol. 2025; 16:1497095.

PMID: 39995661 PMC: 11847652. DOI: 10.3389/fimmu.2025.1497095.

Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization.

Yang W, Yan X, Chen R, Xin X, Ge S, Zhao Y Cell Death Dis. 2025; 16(1):58.

PMID: 39890803 PMC: 11785999. DOI: 10.1038/s41419-025-07376-8.

Comprehensive profiling of serum microRNAs in normal and non-alcoholic fatty liver disease (NAFLD) patients.

Zhang J, Ullah K, Khan N, Pan H Sci Rep. 2025; 15(1):3766.

PMID: 39885249 PMC: 11782575. DOI: 10.1038/s41598-025-87791-1.

Exosome-equipped TNF antisense oligodeoxynucleotide or 2-deoxy-D-glucose ameliorated nonalcoholic steatohepatitis by modulating superoxide dismutase 1 in mice.

He F, Du W, Liu Y, Ling Y, Xu M, Liu J Redox Biol. 2025; 80:103488.

PMID: 39778469 PMC: 11763583. DOI: 10.1016/j.redox.2025.103488.

References

Camma C, Bruno S, Di Marco V, Di Bona D, Rumi M, Vinci M . Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. Hepatology. 2005; 43(1):64-71. DOI: 10.1002/hep.20983. View

Szabo G, Dolganiuc A, Mandrekar P . Pattern recognition receptors: a contemporary view on liver diseases. Hepatology. 2006; 44(2):287-98. DOI: 10.1002/hep.21308. View

Watanabe A, Hashmi A, Gomes D, Town T, Badou A, Flavell R . Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology. 2007; 46(5):1509-18. DOI: 10.1002/hep.21867. View

Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palu G . Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2006; 292(2):G518-25. DOI: 10.1152/ajpgi.00024.2006. View

Nozaki Y, Saibara T, Nemoto Y, Ono M, Akisawa N, Iwasaki S . Polymorphisms of interleukin-1 beta and beta 3-adrenergic receptor in Japanese patients with nonalcoholic steatohepatitis. Alcohol Clin Exp Res. 2004; 28(s2):106S-110S. DOI: 10.1111/j.1530-0277.2004.tb03226.x. View

Bilzer M, Roggel F, Gerbes A . Role of Kupffer cells in host defense and liver disease. Liver Int. 2006; 26(10):1175-86. DOI: 10.1111/j.1478-3231.2006.01342.x. View

Browning J, Horton J . Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004; 114(2):147-52. PMC: 449757. DOI: 10.1172/JCI22422. View

Seki E, Tsutsui H, Nakano H, Tsuji N, Hoshino K, Adachi O . Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta. J Immunol. 2001; 166(4):2651-7. DOI: 10.4049/jimmunol.166.4.2651. View

Bataller R, Brenner D . Liver fibrosis. J Clin Invest. 2005; 115(2):209-18. PMC: 546435. DOI: 10.1172/JCI24282. View

10.

Kawai T, Akira S . The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol. 2009; 21(4):317-37. PMC: 2721684. DOI: 10.1093/intimm/dxp017. View

11.

Ramadori G, Armbrust T . Cytokines in the liver. Eur J Gastroenterol Hepatol. 2001; 13(7):777-84. DOI: 10.1097/00042737-200107000-00004. View

12.

Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. DOI: 10.1007/BF00280883. View

13.

Frances R, Zapater P, Gonzalez-Navajas J, Munoz C, Cano R, Moreu R . Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology. 2008; 47(3):978-85. DOI: 10.1002/hep.22083. View

14.

Chitturi S, Abeygunasekera S, Farrell G, Holmes-Walker J, Hui J, Fung C . NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002; 35(2):373-9. DOI: 10.1053/jhep.2002.30692. View

15.

Inokuchi S, Aoyama T, Miura K, Osterreicher C, Kodama Y, Miyai K . Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc Natl Acad Sci U S A. 2010; 107(2):844-9. PMC: 2818947. DOI: 10.1073/pnas.0909781107. View

16.

Friedman S . Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008; 134(6):1655-69. PMC: 2888539. DOI: 10.1053/j.gastro.2008.03.003. View

17.

Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny M . Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int. 2008; 28(7):1026-33. PMC: 4303249. DOI: 10.1111/j.1478-3231.2008.01723.x. View

18.

Seki E, Brenner D . Toll-like receptors and adaptor molecules in liver disease: update. Hepatology. 2008; 48(1):322-35. DOI: 10.1002/hep.22306. View

19.

Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H . A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408(6813):740-5. DOI: 10.1038/35047123. View

20.

Kleiner D, Brunt E, Van Natta M, Behling C, Contos M, Cummings O . Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41(6):1313-21. DOI: 10.1002/hep.20701. View